Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Çѱ¹ÀÎ À¯¹æ¾Ï ¹× ³­¼Ò¾Ï ȯÀÚ¿¡¼­ BRCA 1 À¯ÀüÀÚÀÇ »ý½Ä¼± µ¹¿¬º¯ÀÌ Germiline Mutation of BRCA1 Gene in Korean Breast and Ovarian Cancer Patients

´ëÇѾÏÇÐȸÁö 1995³â 27±Ç 6È£ p.1061 ~ 1069
¼Ò¼Ó »ó¼¼Á¤º¸
¿ÀÀçȯ ³ëµ¿¿µ/ÃÖ±¹Áø/°­¼ø¹ü/±èÀ̼ö/³ë¸¸¼ö/¹é³²¼±/¾ç´ëÇö/¿À¼¼¹Î

Abstract


We analyzed germline mutations of the BRCAL gene in 29 Korean breast cancer patients, which included ¨ç10 breast cancer patients with family history of breast or ovarian cancer, ¨è 7 early onset breast cancer patients without family history of
breast or
ovarian cancer(less than 40 years old at diagnosis) and ¨é12 breast cancer patients witout family history of breast or ovarian cancer(more than 40 years old at diagnosis), and 1 hereditary ovarian cancer patients, One nonsense mutation at codon
1815
encoding a truncated protein was detected in a breast cancer patients with family history of ovarian cancer. One missense mutation at condon 1630 was detected in a group of breast cancer patients without family history(more than 40 years old at
diagnosis), but still not determined whether it was polymorphism or not. Three polymorphisms were detected, which included 2 cases of silent mutation and a case of missense mutation. In early onset breast cancer group and a familial ovarian
cancer
patient, there was no detected mutation. We confirmed a germline BRCAL gene mutation in one Korean patient of hereditary breast-ovarian cancer family.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS